Pharvaris | EU-Startups

Home Pharvaris

Pharvaris

Category

Business Description

Pharvaris is a clinical-stage company focused on bringing oral bradykinin-B2-receptor antagonists to patients. By targeting this clinically proven therapeutic target with novel small molecules, the Pharvaris team is advancing new alternatives to injected therapies for all sub-types of HAE and other bradykinin-mediated diseases. The company brings together executives with a breadth of expertise across pharmaceutical development and rare disorders, including HAE.

Based in

Zug

Tags

Biotechnology, Life Science, Pharmaceutical

Total Funding

Above €25 million

Founded

2015

Website

https://pharvaris.com/

Articles about Pharvaris:

June 23, 2023 Weekly funding round-up! All of the European startup funding rounds we tracked this week (June 19-23)

💡 You're a corporate or investor and looking for startups that are innovating in the same market as Pharvaris? We're happy to assist you with our Startup Sourcing service.